---
title: "Dian Diagnostics: It is expected that AI business revenue will maintain a compound annual growth rate far exceeding 100% over the next three years"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243623720.md"
description: "Dian Diagnostics expects its AI business revenue to maintain a compound annual growth rate of over 100% in the next three years. In 2024, AI-related business revenue is expected to be approximately 20 million yuan, primarily derived from the commercialization of AI pathology and other auxiliary diagnostic products. The company invests tens of millions of yuan annually in the AI field, focusing on data platforms, pathology AI, and health management. The AI business covers areas such as clinical decision support, health management, pharmaceutical services with AI+CRO, and data infrastructure"
datetime: "2025-06-09T02:56:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243623720.md)
  - [en](https://longbridge.com/en/news/243623720.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243623720.md)
---

# Dian Diagnostics: It is expected that AI business revenue will maintain a compound annual growth rate far exceeding 100% over the next three years

Dian Diagnostics stated in an institutional research that the company's AI-related business revenue in 2024 is expected to be approximately 20 million yuan, mainly derived from the commercialization of AI pathology and other auxiliary diagnostic products and specialized disease database products. The company invests tens of millions of yuan annually in the AI field, focusing primarily on three core areas: data platforms, pathology AI, and health management. According to the three-year strategic plan, the AI business covers four directions: AI-driven clinical decision support, health management, AI + CRO services for pharmaceutical companies, and data foundation and regional "smart inspection linkage" business. It is expected that in the next three years, AI business revenue will maintain a compound annual growth rate far exceeding 100%

### Related Stocks

- [300244.CN](https://longbridge.com/en/quote/300244.CN.md)

## Related News & Research

- [IPO Winners & Losers Podcast: Cerebras, SpaceX, and the AI Takeover](https://longbridge.com/en/news/286957979.md)
- [Is RFK Jr.'s 'carnivore diet' healthy? Here's what you need to know.](https://longbridge.com/en/news/287079002.md)
- [Guriev: Russia is in need of a pipeline to China](https://longbridge.com/en/news/286935918.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [10:19 ETAARC-360 Completes AICPA Peer Review with Pass Rating](https://longbridge.com/en/news/286929747.md)